Patents by Inventor Ron McKay

Ron McKay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080069956
    Abstract: An apparatus and process for monitoring migratory cell proliferation with restricted migration on a substrate includes providing a substrate, coating the substrate with extracellular matrix, plating cells suspended in cell culture media on extracellular matrix, and placing intersecting channels across the extracellular matrix components by removing the extracellular matrix components from the channels to isolate islands of the extracellular matrix components on the substrate. When the cells are immersed with a fluid, migration of the cells is confined to the isolated islands of the extracellular matrix components, permitting long-term observation of a migratory population.
    Type: Application
    Filed: September 28, 2007
    Publication date: March 20, 2008
    Applicant: The Government of the U.S.A., as represented by the Secretary of Health and Human Services
    Inventors: Rea Ravin, James Sullivan, Daniel Hoeppner, David Munno, Ron McKay
  • Patent number: 7276367
    Abstract: An apparatus and process for monitoring migratory cell proliferation with restricted migration on a substrate includes providing a substrate, coating the substrate with extracellular matrix, plating cells suspended in cell culture media on extracellular matrix, and placing intersecting channels across the extracellular matrix components by removing the extracellular matrix components from the channels to isolate islands of the extracellular matrix components on the substrate. When the cells are immersed with a fluid, migration of the cells is confined to the isolated islands of the extracellular matrix components, permitting long-term observation of a migratory population.
    Type: Grant
    Filed: October 14, 2004
    Date of Patent: October 2, 2007
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Rea Ravin, James V. Sullivan, Daniel Hoeppner, David W. Munno, Ron McKay
  • Publication number: 20060084051
    Abstract: An apparatus and process for monitoring migratory cell proliferation with restricted migration on a substrate includes providing a substrate, coating the substrate with extracellular matrix, plating cells suspended in cell culture media on extracellular matrix, and placing intersecting channels across the extracellular matrix components by removing the extracellular matrix components from the channels to isolate islands of the extracellular matrix components on the substrate. When the cells are immersed with a fluid, migration of the cells is confined to the isolated islands of the extracellular matrix components, permitting long-term observation of a migratory population.
    Type: Application
    Filed: October 14, 2004
    Publication date: April 20, 2006
    Applicant: The Govt. of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
    Inventors: Rea Ravin, James Sullivan, Daniel Hoeppner, David Munno, Ron McKay
  • Publication number: 20040005704
    Abstract: The present invention relates to the growth of cells in culture under conditions that promote cell survival, proliferation, and/or cellular differentiation. The present inventors have found that proliferation was promoted and apoptosis reduced when cells were grown in lowered oxygen as compared to environmental oxygen conditions traditionally employed in cell culture techniques. Further, the inventors found that differentiation of precursor cells to specific fates also was enhanced in lowered oxygen where a much greater number and fraction of dopaminergic neurons were obtained when mesencephalic precursors were expanded and differentiated in lowered oxygen conditions. Thus at more physiological oxygen levels the proliferation and differentiation of CNS precursors is enhanced, and lowered oxygen is a useful adjunct for ex vivo generation of specific neuron types. Methods and compositions exploiting these findings are described.
    Type: Application
    Filed: June 13, 2003
    Publication date: January 8, 2004
    Applicants: California Institute of Technology, National Institutes of Health
    Inventors: Marie Csete, John Doyle, Barbara J. Wold, Ron McKay, Lorenz Studer
  • Patent number: 6610540
    Abstract: The present invention relates to the growth of cells in culture under conditions that promote cell survival, proliferation, and/or cellular differentiation. The present inventors have found that proliferation was promoted and apoptosis reduced when cells were grown in lowered oxygen as compared to environmental oxygen conditions traditionally employed in cell culture techniques. Further, the inventors found that differentiation of precursor cells to specific fates also was enhanced in lowered oxygen where a much greater number and fraction of dopaminergic neurons were obtained when mesencephalic precursors were expanded and differentiated in lowered oxygen conditions. Thus at more physiological oxygen levels the proliferation and differentiation of CNS precursors is enhanced, and lowered oxygen is a useful adjunct for ex vivo generation of specific neuron types. Methods and compositions exploiting these findings are described.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: August 26, 2003
    Assignees: California Institute of Technology, National Institutes of Health
    Inventors: Marie Csete, John Doyle, Barbara J. Wold, Ron McKay, Lorenz Studer